PROFUSA, INC. Payments for Merger Related Costs
PROFUSA, INC. (PFSA) had Payments for Merger Related Costs of $25.00 thousand as of 2023-09-29, per its 10-Q filed 2024-12-17.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForMergerRelatedCosts · last filed 2024-12-17
- 2023-09-29: Payments for Merger Related Costs $25.00K.
- 2023-09-14: Payments for Merger Related Costs $25.00K.
| Period end | Payments for Merger Related Costs |
|---|---|
| 2023-09-29 | $25.00K 10-Q · filed 2024-12-17 |
| 2023-09-14 | $25.00K 10-Q · filed 2024-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |